eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Baseline characteristics of the study population

Characteristic Value
Total number of injections performed 9,484
Total number of subjects/eyes 1,480/1,739
Age at time of first injection (years) 59.7 ± 17.6
Sex (male) 842 (56.9)
Injections performed 9,484 (100)
Bevacizumab 5,766 (60.8)
Aflibercept 1,603 (16.9)
Ranibizumab 1,385 (14.6)
Dexamethasone implant 654 (6.9)
Other (antibacterial, antiviral, or antifungal) 76 (0.8)
Follow-up duration (months) 26.3 ± 19.3

Values are presented as mean ± standard deviation or number (%).

J Retin 2020;5:79-84 https://doi.org/10.21561/jor.2020.5.2.79
© 2020 J Retin